ANTIMUTAGENIC POTENTIAL OF LIV52 BY AMES SALMONELLA/MAMMALIAN: MICROSOME MUTAGENICITY ASSAY
Objective: Liv52, a nontoxic herbal preparation is reported to be clinically active in hepatotoxicity and a wide range of hepatic disorders. This study
was undertaken to evaluate the mutagenic/antimutagenic potential of Liv52 using Salmonella mutagenicity test.
Methods: Ames Salmonella/Mammalian - microsome mutagenicity test was used to evaluate the mutagenic or antimutagenic potential of Liv52.
Salmonella typhimurium tester strains TA1537, TA1538, TA100, and TA102 were used for mutagenicity testing. The antimutagenicity study was
carried out in tester strains TA1538 and TA100 against various standard mutagens with and without metabolic activation.
Results: Liv52 did not show any mutagenic potential both with and without metabolic activation, whereas in TA1538 and TA 100 tester strains, Liv52
showed 48.4% and 47.2% of inhibition of his+ revertants induced by 4-nitro-O-phenylenediamine, respectively. Further with metabolic activation
in TA1538, Liv52 showed 99.8%, 99.8%, and 100% inhibition of his+ revertants induced by 2-aminofluorene, 2-anthranine, and cigarette smoke
condensate, respectively. In TA100 maximum of 100%, 100%, 97.7%, and 100% inhibition of his+ revertants induced by 2-aminofluorene, 2-anthranine,
benzo(a)pyrene, and cigarette smoke condensate, respectively, were observed. A significant enhancement of inhibition of his+ revertants induced by
all the above said mutagens were observed in preincubation modification method.
Conclusion: Liv52 was found to be nonmutagenic in Salmonella assay, whereas manifested the antimutagenic potential both with and without
metabolic activation. The enhanced antimutagenic activity of Liv52 on preincubation indicates that the antimutagenic factor(s) may be desmutagenic
in nature. The exact mechanism by which Liv52 exerts antimutagenic potential is not known. The possibility of having diverse antimutagenic factors
in Liv52 which act by different mechanisms are strongly indicated.
Keywords: Liv52 syrup, Salmonella mutagenicity test, Ames test, Desmutagens.
Miyazawa M, Okuno Y, Fukuyama M, Nakamura S, Kosaka H. Antimutagenic activity of polymethoxyflavonoids from Citrus aurantium. J Agric Food Chem 1999;47(12):5239-44.
Prabhu N, Vigneshwari RS, Joseph PI. Antimutagenic effects of compounds obtained from Eclipta alba Linn against strains of Salmonella typhimurium. Int J Bioassays 2012;10(1):102-6.
Radhakrishna M, Hegde MJ. Antimutagenicity of Chyawanprash in Ames test. Int J Pharm Res Health Sci 2016;4(3):1188-94.
Ugur A, SaraÃ§ N, Ã‡ankal DA, Ã–zle M. The antioxidant and antimutagenic activities of Ankaferd blood stopper,a natural hemostatic agent used in dentistry. Turk J Med Sci 2016;46(3):657-63.
Srividya AR, Dhanabal SP, Vishnuvarthan VJ. Mutagenicity/antimutagenicity of plant extracts used in traditional medicine: A review. World J Pharm Res 2013;2(2):236-59.
Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956;11(3):298-300.
Harman D. Mutation, cancer, and ageing. Lancet 1961;1:200-1.
Kamiya H. Mutagenic potentials of damaged nucleic acids produced by reactive oxygen/nitrogen species: Approaches using synthetic oligonucleotides and nucleotides: Survey and summary. Nucleic Acids Res 2003;31(2):517-31.
Ramarathan N, Osawa NT, Namiki M, Tashiro T. Studies on the relationship between antioxidative activity of rice hull and germination ability of rice seeds. J Sci Food Agric 1986;37:719-26.
Fraga CG, Arias RF, Llesuy SF, Koch OR, Boveris A. Effect of vitamin E- and selenium-deficiency on rat liver chemiluminescence. Biochem J 1987;242:383-6.
Maurici D, Aardema M, Corvi R, Kleber M, Krul C, Laurent C, et al. Genotoxicty and mutagenicity. Altern Lab Anim 2005;33 Suppl 1:117-30.
Eastmond DA, Hartwig A, Anderson D, Anwar WA, Cimino MC, Dobrev I, et al. Mutagenicity testing for chemical risk assessment: Update of the WHO/IPCS harmonized scheme. Mutagenesis 2009;24(4):341-9.
Migliore L, CoppedÃ¨ F. Genetic and environmental factors in cancer and neurodegenerative diseases. Mutat Res 2002;512(2-3):135-53.
Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J 2003;17(10):1195-214.
Izzotti A, SaccÃ SC, Cartiglia C, De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med 2003;114(8):638-46.
Weakley SM, Jiang J, Kougias P, Lin PH, Yao Q, Brunicardi FC, et al. Role of somatic mutations in vascular disease formation. Expert Rev Mol Diagn 2010;10(2):173-85.
Sloczynska K, Powroznik B, Pekala E, Waszkielewicz AM. Antimutagenic compounds and their possible mechanisms of action. J Appl Genet 2014;55(2):273-85.
Bonneau D, Thybaud V, Melcion C, Bouhet F, Cordier A. Optimum associations of tester strains for maximum detection of mutagenic compounds in the Ames test. Mutat Res 1991;252(3):269-79.
Maron DM, Ames BN. Revised methods for the Salmonella mutagenicity test. Mutat Res 1983;113(3-4):173-215.
Ong T, Mukhtar M, Wolf CR, Zeiger E. Differential effects of cytochrome p450 inducers on promutagen activation capabilities and enzymatic activities of S9 from rat liver. J Environ Pathol Toxicol 1980;4(1):55-65.
Garner RC, Miller EC, Miller JA. Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530. Cancer Res 1972;32(10):2058-66.
Kada T, Morita K, Inoue T. Anti-mutagenic action of vegetable factor(s) on the mutagenic principle of tryptophan pyrolysate. Mutat Res 1978;53(3):351-3.
Kuroda Y, Jain AK, Tezuka H, Kada T. Antimutagenicity in cultured mammalian cells. Mutat Res 1992;267(2):201-9.
Geetha B, Santhy KS. Evaluation of antimutagenic activity of orange peel extract using Ames Salmonella microsome assay. Int J Life Sci Biotechnol Pharm Res 2013;2(3):466-71.
Teixeira RO, Camparoto ML, Mantovani MS. Assessment of two medicinal plants, Psidium guajava L. and Achillea millefolium L, In vitro and in vivo assays. Genet Mol Biol 2003;26(4):551-5.
How to Cite
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.